116 related articles for article (PubMed ID: 8300642)
1. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
Herbert JM; Lamarche I; Prabonnaud V; Dol F; Gauthier T
J Biol Chem; 1994 Jan; 269(4):3076-80. PubMed ID: 8300642
[TBL] [Abstract][Full Text] [Related]
2. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
Xiaoli M; Wenying H; Mingpeng S
Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
[TBL] [Abstract][Full Text] [Related]
3. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
Herbert JM; Lamarche I; Carmeliet P
J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
[TBL] [Abstract][Full Text] [Related]
4. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis.
Au YP; Kenagy RD; Clowes AW
J Biol Chem; 1992 Feb; 267(5):3438-44. PubMed ID: 1310687
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
6. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis.
Rossignol P; Anglès-Cano E; Lijnen HR
Thromb Haemost; 2006 Nov; 96(5):665-70. PubMed ID: 17080225
[TBL] [Abstract][Full Text] [Related]
8. Lead perturbs the regulation of spontaneous release of tissue plasminogen activator and plasminogen activator inhibitor-1 from vascular smooth muscle cells and fibroblasts in culture.
Yamamoto C; Miyamoto A; Sakamoto M; Kaji T; Kozuka H
Toxicology; 1997 Feb; 117(2-3):153-61. PubMed ID: 9057894
[TBL] [Abstract][Full Text] [Related]
9. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
12. Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H
Toxicology; 1996 Jan; 106(1-3):179-85. PubMed ID: 8571389
[TBL] [Abstract][Full Text] [Related]
13. Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells.
Herbert JM; Carmeliet P
FEBS Lett; 1997 Aug; 413(3):401-4. PubMed ID: 9303544
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.
De Petro G; Copeta A; Barlati S
Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PA.
Herbert JM; Bono F; Lamarche I; Carmeliet P
Thromb Res; 1997 May; 86(4):317-24. PubMed ID: 9187019
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor increases plasminogen activator inhibitor-1 activity and mRNA in rat cultured vascular smooth muscle.
Sperti G; van Leeuwen R; Maseri A; Kluft C
Ann N Y Acad Sci; 1992 Dec; 667():178-80. PubMed ID: 1309033
[No Abstract] [Full Text] [Related]
17. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
Okada SS; Grobmyer SR; Barnathan ES
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1269-76. PubMed ID: 8857924
[TBL] [Abstract][Full Text] [Related]
18. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.
McNamara CA; Sarembock IJ; Gimple LW; Fenton JW; Coughlin SR; Owens GK
J Clin Invest; 1993 Jan; 91(1):94-8. PubMed ID: 8380817
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells.
Yu SM; Tsai SY; Guh JH; Ko FN; Teng CM; Ou JT
Circulation; 1996 Aug; 94(3):547-54. PubMed ID: 8759101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
